Improving Health Care and Innovating With Ristenza®

Avagen Pharma, Inc. focuses on cutting-edge technology and innovation to create disruptive products designed to improve healthcare for patients. After years of research and development with world-renowned scientists, Avagen has created the innovative solution to treat Premature Ejaculation. This solution is known as Ristenza®, designed to extend a couple’s intimacy. Ristenza® is an innovative approach for the treatment of Premature Ejaculation (PE). Ristenza® employs an “off-label use” of FDA-approved, multi-drug capsule that provides highly effective relief for PE with none of the hassles associated with other currently available remedies. Ristenza® can be administered in dosages that permit the user to adjust the level of performance from minimal to complete control of their sexual experience. No other remedy combines the ease of use, safety and effectiveness of Ristenza®

NanoProRx™

Transforming medication therapy to its most safe and effective form.

Learn more about the technology
Ristenza®

Bringing couples together by enhancing the sexual experience.

For Consumers
For Providers

“In the end, it’s not the years in your life that count. It’s the life in your years.”

“In the end, it’s not the years in your life that count. It’s the life in your years.”

-Abraham Lincoln

AVAGEN PHARMA
RistenzaTM by AVAGEN PHARMA

Avagen Pharma Inc. using innovation and technology to advance unmet clinical and medical needs.

Avagen Pharma Inc. using innovation and technology to advance unmet clinical and medical needs.

Learn about our products